𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk

✍ Scribed by Lindmark, F; Zheng, S L; Wiklund, F; Bälter, K A; Sun, J; Chang, B; Hedelin, M; Clark, J; Johansson, J-E; Meyers, D A

Book ID
109998592
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
92 KB
Volume
93
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin 1 receptor antagonist gene p
Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus
✍ Frances E. Clay; Michael J. Cork; Joanna K. Tarlow; Alexandra I. F. Blakemore; C 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 404 KB

Cytokines play key roles in immune responses, inflammation and fibrosis. The balance between levels of cytokines, their receptors and specific inhibitors controls inflammatory reactions in tissues. The pathogenesis of lichen sclerosus is unknown but probably involves cytokine mediators such as inter

Interleukin-1-β gene, but not the interl
Interleukin-1-β gene, but not the interleukin-1 receptor antagonist gene, is associated with graves' disease
✍ Rong-Hsing Chen; Wen-Chi Chen; Chwen-Tzuei Chang; Chang-Hai Tsai; Fuu-Jen Tsai 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

## Abstract Interleukin‐1 (IL‐1) is considered to be involved in the pathogenesis of Graves' disease. The aim of this study was to test whether the IL‐1‐β gene promoter region and exon 5 and IL‐1 receptor antagonist (IL‐1Ra) gene intron 2 polymorphisms could be useful genetic markers for susceptibi

Androgen receptor polymorphisms: Associa
Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival
✍ Stephen M. Edwards; Mike D. Badzioch; Ralph Minter; Rifat Hamoudi; Nadine Collin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 179 KB 👁 1 views

Several reports have suggested that one or both of the trinucleotide repeat polymorphisms in the human androgen receptor (hAR) gene, (CAG) n coding for polyglutamine and (GGC) n coding for polyglycine, may be associated with prostate cancer risk; but no study has investigated their association with